302
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Cardiorespiratory Fitness and Quality-of-Life Analysis Posttreatment in Breast Cancer Survivors

, , , , , & show all
Pages 381-398 | Published online: 08 Jul 2010
 

Abstract

This study compared VO2peak, treatment frequency and dosage, and QOL between 22 post-treated breast cancer survivors (CATotal) and 22 apparently healthy, age-matched women (CO). The CATotal group included 11 with no history of any other co-morbidities (CA) and 11 with controlled hypertension (CA + H). VO2peak was measured using the Bruce Protocol. QOL was measured using the SF-36 survey. Significant differences were observed in VO2peak between CATotal and CO (p = 0.014), CA and CA + H (p = 0.001), and CA + H and CO (p = 0.001). Physical, emotional, and mental health domains of the SF-36 were significantly different between CATotal and CO (p = 0.006, 0.001, and 0.05 respectively). These results suggest that breast cancer survivors with controlled hypertension can experience a significant reduction in VO2peak when compared to apparently healthy, age-matched controls. Also, treatment frequency and dosage affected QOL in this group of survivors.

Notes

*Significant difference in number of radiation fractions received between CA and CA + H (p ≤ 0.05),

**Significant difference in total dose of radiation received between CA and CA + H (p ≤ 0.05).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.